Polysaccharide-Based Bioactive Hydrogels for Diabetic Wound Management

Abstract

Diabetic wound management constitutes a major clinical burden due to its complex and multifactorial pathophysiology involving dysregulated immune response, prolonged inflammation, impaired angiogenesis, abnormal neovascularization, and dysfunctional endothelial cell activity. This review focuses on polysaccharide-based bioactive hydrogels (PBHs) as advanced dressings for diabetic wound management. PBHs offer inherent therapeutic properties, including antioxidant, anti-inflammatory, antimicrobial, and immunomodulatory effects, along with a remarkable functionalization potential that enables tailored interventions for complex wound environments. The innovative aspect of this review lies in highlighting the mechanistic roles of PBHs in modulating oxidative stress, promoting angiogenesis, regulating macrophage polarization, and enhancing antibacterial defense, thereby accelerating wound healing. Furthermore, the current limitations hindering the clinical translation of PBHs are also discussed.

Article information

Article type
Review Article
Submitted
04 Nov 2025
Accepted
07 Apr 2026
First published
15 Apr 2026
This article is Open Access
Creative Commons BY license

RSC Pharm., 2026, Accepted Manuscript

Polysaccharide-Based Bioactive Hydrogels for Diabetic Wound Management

A. Dhar, K. Mukherjee and T. K. Giri, RSC Pharm., 2026, Accepted Manuscript , DOI: 10.1039/D5PM00306G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements